Kenneth Bender

Some atopic dermatitis patients at risk for developing contact dermatitis from certain common ingredients in topical products.

Patients who discontinued long-term treatment with omalizumab more likely to experience severe asthma exacerbation.

Ustekinumab is a monoclonal antibody approved by the FDA to treat plaque psoriasis, psoriatic arthritis, and active Crohn's disease.